Combining genetic algorithm with machine learning strategies for designing potent antimicrobial peptides
Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes...
Saved in:
| Published in: | BMC bioinformatics Vol. 22; no. 1; pp. 239 - 17 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
11.05.2021
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects: | |
| ISSN: | 1471-2105, 1471-2105 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space.
Methods
Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process.
Results
We use supervised machine learning and a genetic algorithm to find a peptide active against
S. epidermidis
, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis.
Conclusions
Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. |
|---|---|
| AbstractList | Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space.
Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process.
We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis.
Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space. Methods Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process. Results We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis , a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis. Conclusions Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space. Methods Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process. Results We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis. Conclusions Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. Keywords: Antibacterial, Antimicrobial peptide, Machine learning, Rough set theory, Genetic algorithm Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space. Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process. We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis. Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space. Methods Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process. Results We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis. Conclusions Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. Abstract Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space. Methods Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process. Results We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis. Conclusions Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space.BACKGROUNDCurrent methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural networking methods have state-of-the-art performance, their vulnerability in decision making processes leading to irrational outcomes is a major concern for their implementation. With the rising antibiotic resistance, antimicrobial peptides (AMPs) have increasingly gained attention as novel therapeutic agents. This challenging design problem requires peptides which meet the multiple constraints of limiting drug-resistance in bacteria, preventing secondary infections from imbalanced microbial flora, and avoiding immune system suppression. AMPs offer a promising, bioinspired design space to targeting antimicrobial activity, but their versatility also requires the curated selection from a combinatorial sequence space. This space is too large for brute-force methods or currently known rational design approaches outside of machine learning. While there has been progress in using the design space to more effectively target AMP activity, a widely applicable approach has been elusive. The lack of transparency in machine learning has limited the advancement of scientific knowledge of how AMPs are related among each other, and the lack of general applicability for fully rational approaches has limited a broader understanding of the design space.Here we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process.METHODSHere we combined an evolutionary method with rough set theory, a transparent machine learning approach, for designing antimicrobial peptides (AMPs). Our method achieves the customization of AMPs using supervised learning boundaries. Our system employs in vitro bacterial assays to measure fitness, codon-representation of peptides to gain flexibility of sequence selection in DNA-space with a genetic algorithm and machine learning to further accelerate the process.We use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis.RESULTSWe use supervised machine learning and a genetic algorithm to find a peptide active against S. epidermidis, a common bacterial strain for implant infections, with an improved aggregation propensity average for an improved ease of synthesis.Our results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences.CONCLUSIONSOur results demonstrate that AMP design can be customized to maintain activity and simplify production. To our knowledge, this is the first time when codon-based genetic algorithms combined with rough set theory methods is used for computational search on peptide sequences. |
| ArticleNumber | 239 |
| Audience | Academic |
| Author | Boone, Kyle Wisdom, Cate Tamerler, Candan Camarda, Kyle Spencer, Paulette |
| Author_xml | – sequence: 1 givenname: Kyle surname: Boone fullname: Boone, Kyle organization: Bioengineering Program, University of Kansas, Institute of Bioengineering Research, University of Kansas – sequence: 2 givenname: Cate surname: Wisdom fullname: Wisdom, Cate organization: Bioengineering Program, University of Kansas, Institute of Bioengineering Research, University of Kansas – sequence: 3 givenname: Kyle surname: Camarda fullname: Camarda, Kyle organization: Chemical and Petroleum Engineering Department, University of Kansas – sequence: 4 givenname: Paulette surname: Spencer fullname: Spencer, Paulette organization: Mechanical Engineering Department, University of Kansas, Institute of Bioengineering Research, University of Kansas – sequence: 5 givenname: Candan orcidid: 0000-0002-1960-2218 surname: Tamerler fullname: Tamerler, Candan email: ctamerler@ku.edu organization: Mechanical Engineering Department, University of Kansas, Institute of Bioengineering Research, University of Kansas |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33975547$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktr3DAUhU1JaR7tH-iiGLppF04lWbKtTSEMfQwECn2shR7XHg22NJU07fTfV55Jk0wowWDL0neOdK_OeXHivIOieInRJcZd8y5i0jFeIYIrRDFrqt2T4gzTFlcEI3Zyb3xanMe4Rgi3HWLPitO65i1jtD0rVgs_KeusG8oBHCSrSzkOPti0msrf-V1OUq-sg3IEGfZcTEEmGCzEsvehNBDtsF_Y-AQuldIlO1kdvLJyLDewSTYzz4unvRwjvLj5XhQ_Pn74vvhcXX_5tFxcXVe6oThVDXSdxkTlH0oUxpwT2ivNZceNpgwZ1PSGtlwazUBBlwltpGTQN6rDPa8viuXB13i5FptgJxn-CC-t2E_4MAgZcpkjCKU0kbjBQDmiVLWqbVXd1pr3iBlDTfZ6f_DabNUERufqghyPTI9XnF2Jwf8S-ViYsy4bvLkxCP7nFmISk40axlE68NsoCCMNZpggmtHXD9C13waXWzVTHUd1TckdNchcgHW9z_vq2VRcNQ2jNWrI7HX5Hyo_BvLF5BD1Ns8fCd4eCTKTYJcGuY1RLL99PWZf3W_KbTf-ZSoD5ADkCMQYoL9FMBJzcMUhuCIHV-yDK3ZZ1D0QaZtksn5urB0fl9YHacz7uAHCXeceUf0FIMYC-A |
| CitedBy_id | crossref_primary_10_3389_fdmed_2024_1372534 crossref_primary_10_1016_j_copbio_2022_102718 crossref_primary_10_1016_j_heliyon_2024_e40265 crossref_primary_10_1016_j_jpha_2024_101046 crossref_primary_10_1038_s41467_023_36994_z crossref_primary_10_3390_microorganisms12081682 crossref_primary_10_1002_smll_202305375 crossref_primary_10_1002_advs_202503443 crossref_primary_10_1016_j_csbj_2023_09_038 crossref_primary_10_1039_D3ME00109A crossref_primary_10_1016_j_scitotenv_2024_172150 crossref_primary_10_1109_TCBB_2024_3411024 crossref_primary_10_1016_j_biortech_2022_128522 crossref_primary_10_3390_molecules29204889 crossref_primary_10_1111_myc_70007 crossref_primary_10_3389_fdmed_2022_1007753 crossref_primary_10_1016_j_ijantimicag_2025_107611 crossref_primary_10_1016_j_ejmech_2023_116072 crossref_primary_10_3390_microorganisms12050842 crossref_primary_10_1371_journal_pone_0315477 crossref_primary_10_3390_ijms22126552 crossref_primary_10_1016_j_bioactmat_2021_08_014 crossref_primary_10_3389_fcimb_2022_1065235 crossref_primary_10_3389_fmicb_2024_1370826 crossref_primary_10_1021_acs_biomac_5c00244 crossref_primary_10_1016_j_alit_2025_08_006 crossref_primary_10_1111_jam_15314 crossref_primary_10_3390_ijms23137404 crossref_primary_10_1108_ILT_06_2023_0196 crossref_primary_10_1557_s43580_023_00629_8 crossref_primary_10_3389_fmicb_2023_1116766 crossref_primary_10_1002_adbi_202400461 crossref_primary_10_21468_SciPostChem_4_1_001 crossref_primary_10_1002_adhm_202101113 crossref_primary_10_1016_j_neucom_2024_127758 crossref_primary_10_1016_j_biotechadv_2022_107968 crossref_primary_10_1016_j_biochi_2025_07_019 crossref_primary_10_1016_j_tifs_2025_104887 crossref_primary_10_3390_antibiotics11101451 crossref_primary_10_3390_app15052608 crossref_primary_10_1016_j_mib_2023_102305 crossref_primary_10_3389_fphar_2022_864412 crossref_primary_10_3390_antibiotics11070936 crossref_primary_10_1038_s44222_024_00152_x crossref_primary_10_1016_j_drudis_2023_103629 crossref_primary_10_1007_s10462_025_11148_3 |
| Cites_doi | 10.1371/journal.pone.0045848 10.1186/1741-7007-4-41 10.1038/s41598-017-16221-8 10.1016/j.cep.2008.02.008 10.1111/j.1747-0285.2010.01044.x 10.1038/nature10388 10.1021/acsbiomaterials.9b01213 10.1371/journal.pcbi.1005324 10.1002/pro.5560041006 10.1038/nature24270 10.3390/app9030557 10.1016/j.dci.2018.05.002 10.1007/s11837-015-1350-7 10.1186/s12859-016-1199-y 10.1080/019697298125470 10.1007/s10844-015-0385-0 10.1016/j.ab.2013.01.019 10.1016/j.chempr.2018.01.005 10.1016/j.compchemeng.2004.10.008 10.1109/BIBM.2015.7359652 10.1038/s41598-020-58014-6 10.1093/nar/gkv1278 10.1007/978-1-4939-6737-7_1 10.1109/AISP.2012.6313744 10.1016/j.jtbi.2016.09.018 10.1109/ICCV.2015.425 10.1016/j.jsb.2017.09.001 10.1080/00031305.1998.10480559 10.4236/jcc.2016.49002 10.1038/s41598-016-0001-8 10.1186/1471-2105-8-65 10.1002/pro.5560060605 10.1002/cphc.201601034 10.1021/acs.jcim.7b00414 10.1093/bioinformatics/bty179 10.1186/s12859-018-2514-6 10.1371/journal.pone.0097539 10.1002/prot.22488 10.1186/s13040-019-0196-x 10.1016/j.ijid.2016.11.415 10.1016/j.dci.2019.103471 10.1023/A:1008095802767 10.1002/pro.5560030405 10.1093/nar/gkm998 10.1038/227561a0 10.1016/j.compchemeng.2015.03.009 10.1016/j.intimp.2018.10.021 10.1177/0022034516679973 10.1016/j.tim.2015.11.004 10.1371/journal.pone.0135961 10.1021/acsami.5b03697 10.1038/nrd3591 10.1007/978-981-13-3588-4_1 10.1016/B978-0-444-63683-6.00008-3 10.1016/S1473-3099(15)00424-7 10.1073/pnas.1821309116 10.1016/j.bbamem.2008.10.020 10.1039/C9SC03532J 10.1021/acsapm.9b00921 10.2174/157489309787158134 10.1016/j.bpj.2019.11.310 10.1142/S2251237316400050 10.1006/jmbi.1996.0897 10.1109/TCBB.2015.2462364 10.1038/d41586-019-03013-5 10.1002/mds3.10144 10.1016/j.actbio.2016.11.026 10.1021/cb800240j 10.1016/j.bbagen.2018.06.011 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QO 7SC 7X7 7XB 88E 8AL 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ JQ2 K7- K9. L7M LK8 L~C L~D M0N M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA |
| DOI | 10.1186/s12859-021-04156-x |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Biotechnology Research Abstracts Computer and Information Systems Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Computing Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central (subscription) Technology collection Natural Science Collection ProQuest One ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Computer Science Collection Computer Science Database ProQuest Health & Medical Complete (Alumni) Advanced Technologies Database with Aerospace ProQuest Biological Science Collection Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Computing Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Computer Science Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Computer Science Collection Computer and Information Systems Abstracts SciTech Premium Collection ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database Computer and Information Systems Abstracts – Academic ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Advanced Technologies Database with Aerospace ProQuest Computing ProQuest Central Basic ProQuest Computing (Alumni Edition) ProQuest SciTech Collection Computer and Information Systems Abstracts Professional Advanced Technologies & Aerospace Database ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1471-2105 |
| EndPage | 17 |
| ExternalDocumentID | oai_doaj_org_article_bbc2a161e49044b7b77b373c9f05dd4d PMC8111958 A665430624 33975547 10_1186_s12859_021_04156_x |
| Genre | Journal Article |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: National Institute of Dental and Craniofacial Research grantid: R01DE025476; R01DE025476 funderid: http://dx.doi.org/10.13039/100000072 – fundername: NIDCR NIH HHS grantid: R01 DE025476 – fundername: NIDCR NIH HHS grantid: R01DE025476 – fundername: ; grantid: R01DE025476; R01DE025476 |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAFWJ AAJSJ AAKPC AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADMLS ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ARAPS AZQEC BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 DWQXO E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO ICD IHR INH INR ISR ITC K6V K7- KQ8 LK8 M1P M48 M7P MK~ ML0 M~E O5R O5S OK1 OVT P2P P62 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XH6 XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QO 7SC 7XB 8AL 8FD 8FK FR3 JQ2 K9. L7M L~C L~D M0N P64 PKEHL PQEST PQUKI Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c641t-6e88c12b64142b119924fbc9a89dc450d06fd479adc5ebe8119cdaa5ef6b81f93 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 55 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000655599300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2105 |
| IngestDate | Fri Oct 03 12:53:19 EDT 2025 Tue Nov 04 01:48:28 EST 2025 Sun Nov 09 09:26:51 EST 2025 Mon Oct 06 18:20:34 EDT 2025 Tue Nov 11 10:21:01 EST 2025 Tue Nov 04 17:58:32 EST 2025 Thu Nov 13 14:58:20 EST 2025 Thu Apr 03 07:02:38 EDT 2025 Sat Nov 29 05:40:09 EST 2025 Tue Nov 18 21:53:05 EST 2025 Sat Sep 06 07:27:36 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Rough set theory Antibacterial Genetic algorithm Machine learning Antimicrobial peptide |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c641t-6e88c12b64142b119924fbc9a89dc450d06fd479adc5ebe8119cdaa5ef6b81f93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-1960-2218 |
| OpenAccessLink | https://doaj.org/article/bbc2a161e49044b7b77b373c9f05dd4d |
| PMID | 33975547 |
| PQID | 2528903342 |
| PQPubID | 44065 |
| PageCount | 17 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_bbc2a161e49044b7b77b373c9f05dd4d pubmedcentral_primary_oai_pubmedcentral_nih_gov_8111958 proquest_miscellaneous_2526151204 proquest_journals_2528903342 gale_infotracmisc_A665430624 gale_infotracacademiconefile_A665430624 gale_incontextgauss_ISR_A665430624 pubmed_primary_33975547 crossref_primary_10_1186_s12859_021_04156_x crossref_citationtrail_10_1186_s12859_021_04156_x springer_journals_10_1186_s12859_021_04156_x |
| PublicationCentury | 2000 |
| PublicationDate | 2021-05-11 |
| PublicationDateYYYYMMDD | 2021-05-11 |
| PublicationDate_xml | – month: 05 year: 2021 text: 2021-05-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC bioinformatics |
| PublicationTitleAbbrev | BMC Bioinformatics |
| PublicationTitleAlternate | BMC Bioinformatics |
| PublicationYear | 2021 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | D Heaven (4156_CR3) 2019; 574 J Lei (4156_CR27) 2019; 11 M Movahedi (4156_CR61) 2016; 17 AT Muller (4156_CR37) 2018; 58 Z Abbas (4156_CR7) 2016; 4 L Xu (4156_CR34) 2020; 10 S Spänig (4156_CR46) 2019; 12 DH Simpson (4156_CR17) 2019; 10 X Xiao (4156_CR75) 2013; 436 H Yazici (4156_CR22) 2016; 8 K Boone (4156_CR40) 2017; 39 JR Desjarlais (4156_CR59) 1995; 4 C Wisdom (4156_CR23) 2016; 4 B Lin (4156_CR42) 2005; 29 SX Xie (4156_CR21) 2019; 9 GA Lazar (4156_CR57) 1997; 6 S Wang (4156_CR5) 2017; 13 VM D'Costa (4156_CR69) 2011; 477 4156_CR2 M Korichi (4156_CR54) 2008; 47 S Giannerini (4156_CR65) 2012; 370 F Crick (4156_CR76) 1970; 227 JV Lorenzo-Ginori (4156_CR64) 2009; 4 4156_CR9 S Kawashima (4156_CR73) 2008; 36 S Mai (4156_CR31) 2017; 49 PG Clark (4156_CR8) 2016; 47 S Lebre (4156_CR66) 2017; 415 S-X Xie (4156_CR25) 2020; 2 S Spanig (4156_CR6) 2019; 12 CT Yeh (4156_CR60) 2018; 201 CD Fjell (4156_CR43) 2011; 77 H Choi (4156_CR16) 2016; 24 JL Hintze (4156_CR50) 1998; 52 4156_CR55 DT Jones (4156_CR68) 1994; 3 4156_CR15 G Jones (4156_CR56) 1997; 267 L Fan (4156_CR30) 2016; 6 AM Czyzewski (4156_CR32) 2016; 11 YY Liu (4156_CR11) 2016; 16 M Yoshida (4156_CR18) 2018; 4 S Rotem (4156_CR33) 2009; 1788 E Brunk (4156_CR62) 2016; 17 B Bechinger (4156_CR19) 2017; 96 D Veltri (4156_CR38) 2017; 14 EC Wisdom (4156_CR26) 2019; 6 G Wang (4156_CR29) 2016; 44 GG Krivov (4156_CR58) 2009; 77 D Silver (4156_CR1) 2017; 550 D Veltri (4156_CR44) 2018; 34 4156_CR45 A Afshar (4156_CR20) 2021; 4 DT Yucesoy (4156_CR24) 2015; 67 4156_CR49 LY Ng (4156_CR41) 2015; 81 WF Porto (4156_CR35) 2018; 1862 Z Li (4156_CR51) 2014; 9 4156_CR70 JA Al-Tawfiq (4156_CR10) 2017; 54 A Strzepa (4156_CR12) 2018; 65 A Cherkasov (4156_CR39) 2009; 4 AF Dishman (4156_CR28) 2020; 118 O Conchillo-Sole (4156_CR48) 2007; 8 S Patel (4156_CR67) 1998; 12 Z Pawlak (4156_CR72) 1998; 29 EM Gertz (4156_CR52) 2006; 4 CH Kim (4156_CR14) 2018; 86 JW Grzymala-Busse (4156_CR74) 2010; 100 K Boone (4156_CR47) 2018; 19 J Xu (4156_CR4) 2019; 116 GD Brand (4156_CR53) 2012; 7 CD Fjell (4156_CR71) 2012; 11 4156_CR36 V Opuu (4156_CR63) 2017; 7 M Shelomi (4156_CR13) 2020; 103 |
| References_xml | – volume: 7 start-page: e45848 year: 2012 ident: 4156_CR53 publication-title: Plos One. doi: 10.1371/journal.pone.0045848 – volume: 4 start-page: 41 year: 2006 ident: 4156_CR52 publication-title: BMC Biol doi: 10.1186/1741-7007-4-41 – volume: 7 start-page: 15873 year: 2017 ident: 4156_CR63 publication-title: Sci Rep doi: 10.1038/s41598-017-16221-8 – volume: 47 start-page: 1902 year: 2008 ident: 4156_CR54 publication-title: Chem Eng Process doi: 10.1016/j.cep.2008.02.008 – volume: 77 start-page: 48 year: 2011 ident: 4156_CR43 publication-title: Chem Biol Drug Des doi: 10.1111/j.1747-0285.2010.01044.x – volume: 477 start-page: 457 year: 2011 ident: 4156_CR69 publication-title: Nature doi: 10.1038/nature10388 – volume: 6 start-page: 2682 year: 2019 ident: 4156_CR26 publication-title: ACS Biomater Sci Eng doi: 10.1021/acsbiomaterials.9b01213 – volume: 13 start-page: e 1005324 year: 2017 ident: 4156_CR5 publication-title: PLoS Comput Biol. doi: 10.1371/journal.pcbi.1005324 – volume: 4 start-page: 2006 year: 1995 ident: 4156_CR59 publication-title: Protein Sci doi: 10.1002/pro.5560041006 – volume: 550 start-page: 354 year: 2017 ident: 4156_CR1 publication-title: Nature doi: 10.1038/nature24270 – volume: 9 start-page: 557 year: 2019 ident: 4156_CR21 publication-title: Appl Sci (Basel) doi: 10.3390/app9030557 – volume: 86 start-page: 203 year: 2018 ident: 4156_CR14 publication-title: Dev Comp Immunol doi: 10.1016/j.dci.2018.05.002 – ident: 4156_CR9 – volume: 67 start-page: 754 year: 2015 ident: 4156_CR24 publication-title: JOM doi: 10.1007/s11837-015-1350-7 – volume: 17 start-page: 353 year: 2016 ident: 4156_CR61 publication-title: BMC Bioinformatics doi: 10.1186/s12859-016-1199-y – volume: 29 start-page: 661 year: 1998 ident: 4156_CR72 publication-title: Cybern Syst doi: 10.1080/019697298125470 – volume: 47 start-page: 515 year: 2016 ident: 4156_CR8 publication-title: J Intell Inf Syst doi: 10.1007/s10844-015-0385-0 – volume: 370 start-page: 2987 year: 2012 ident: 4156_CR65 publication-title: Philos Trans A Math Phys Eng Sci – volume: 436 start-page: 168 year: 2013 ident: 4156_CR75 publication-title: Anal Biochem doi: 10.1016/j.ab.2013.01.019 – volume: 4 start-page: 533 year: 2018 ident: 4156_CR18 publication-title: Chem doi: 10.1016/j.chempr.2018.01.005 – volume: 29 start-page: 337 year: 2005 ident: 4156_CR42 publication-title: Comput Chem Eng doi: 10.1016/j.compchemeng.2004.10.008 – ident: 4156_CR70 doi: 10.1109/BIBM.2015.7359652 – volume: 10 start-page: 944 year: 2020 ident: 4156_CR34 publication-title: Sci Rep doi: 10.1038/s41598-020-58014-6 – volume: 44 start-page: D1087 year: 2016 ident: 4156_CR29 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkv1278 – ident: 4156_CR49 doi: 10.1007/978-1-4939-6737-7_1 – ident: 4156_CR55 doi: 10.1109/AISP.2012.6313744 – volume: 415 start-page: 90 year: 2017 ident: 4156_CR66 publication-title: J Theor Biol doi: 10.1016/j.jtbi.2016.09.018 – ident: 4156_CR2 doi: 10.1109/ICCV.2015.425 – volume: 201 start-page: 100 year: 2018 ident: 4156_CR60 publication-title: J Struct Biol doi: 10.1016/j.jsb.2017.09.001 – volume: 52 start-page: 181 year: 1998 ident: 4156_CR50 publication-title: Am Stat doi: 10.1080/00031305.1998.10480559 – volume: 4 start-page: 10 year: 2016 ident: 4156_CR7 publication-title: J Comput Commun doi: 10.4236/jcc.2016.49002 – volume: 6 start-page: 1 year: 2016 ident: 4156_CR30 publication-title: Sci Rep doi: 10.1038/s41598-016-0001-8 – volume: 8 start-page: 65 year: 2007 ident: 4156_CR48 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-8-65 – volume: 6 start-page: 1167 year: 1997 ident: 4156_CR57 publication-title: Protein Sci doi: 10.1002/pro.5560060605 – volume: 17 start-page: 3831 year: 2016 ident: 4156_CR62 publication-title: ChemPhysChem doi: 10.1002/cphc.201601034 – volume: 58 start-page: 472 year: 2018 ident: 4156_CR37 publication-title: J Chem Inf Model doi: 10.1021/acs.jcim.7b00414 – volume: 34 start-page: 2740 year: 2018 ident: 4156_CR44 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty179 – volume: 19 start-page: 1 year: 2018 ident: 4156_CR47 publication-title: BMC Bioinformatics doi: 10.1186/s12859-018-2514-6 – volume: 9 start-page: e 97539 year: 2014 ident: 4156_CR51 publication-title: PLoS One. doi: 10.1371/journal.pone.0097539 – volume: 77 start-page: 778 year: 2009 ident: 4156_CR58 publication-title: Proteins doi: 10.1002/prot.22488 – volume: 12 start-page: 7 year: 2019 ident: 4156_CR6 publication-title: BioData Min doi: 10.1186/s13040-019-0196-x – volume: 54 start-page: 77 year: 2017 ident: 4156_CR10 publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2016.11.415 – volume: 103 start-page: 103471 year: 2020 ident: 4156_CR13 publication-title: Dev Comp Immunol. doi: 10.1016/j.dci.2019.103471 – volume: 12 start-page: 543 year: 1998 ident: 4156_CR67 publication-title: J Comput Aided Mol Des doi: 10.1023/A:1008095802767 – volume: 3 start-page: 567 year: 1994 ident: 4156_CR68 publication-title: Protein Sci doi: 10.1002/pro.5560030405 – volume: 36 start-page: D202 year: 2008 ident: 4156_CR73 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkm998 – volume: 227 start-page: 561 year: 1970 ident: 4156_CR76 publication-title: Nature doi: 10.1038/227561a0 – volume: 81 start-page: 115 year: 2015 ident: 4156_CR41 publication-title: Comput Chem Eng doi: 10.1016/j.compchemeng.2015.03.009 – volume: 65 start-page: 328 year: 2018 ident: 4156_CR12 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2018.10.021 – volume: 96 start-page: 254 year: 2017 ident: 4156_CR19 publication-title: J Dent Res doi: 10.1177/0022034516679973 – volume: 24 start-page: 111 year: 2016 ident: 4156_CR16 publication-title: Trends Microbiol doi: 10.1016/j.tim.2015.11.004 – volume: 11 start-page: e 0135961 year: 2016 ident: 4156_CR32 publication-title: PLoS One. doi: 10.1371/journal.pone.0135961 – volume: 8 start-page: 5070 year: 2016 ident: 4156_CR22 publication-title: ACS Appl Mater Interfaces. doi: 10.1021/acsami.5b03697 – volume: 11 start-page: 37 year: 2012 ident: 4156_CR71 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3591 – ident: 4156_CR15 doi: 10.1007/978-981-13-3588-4_1 – volume: 39 start-page: 221 year: 2017 ident: 4156_CR40 publication-title: Comput Aided Chem Eng doi: 10.1016/B978-0-444-63683-6.00008-3 – volume: 16 start-page: 161 year: 2016 ident: 4156_CR11 publication-title: Lancet Infect Dis. doi: 10.1016/S1473-3099(15)00424-7 – volume: 116 start-page: 16856 year: 2019 ident: 4156_CR4 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1821309116 – volume: 1788 start-page: 1582 year: 2009 ident: 4156_CR33 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamem.2008.10.020 – ident: 4156_CR45 – volume: 10 start-page: 9708 year: 2019 ident: 4156_CR17 publication-title: Chem Sci doi: 10.1039/C9SC03532J – volume: 2 start-page: 1134 year: 2020 ident: 4156_CR25 publication-title: ACS Appl Polym Mater doi: 10.1021/acsapm.9b00921 – volume: 4 start-page: 28 year: 2009 ident: 4156_CR64 publication-title: Curr Bioinform doi: 10.2174/157489309787158134 – volume: 100 start-page: 99 year: 2010 ident: 4156_CR74 publication-title: Fund Inform – volume: 12 start-page: 7 year: 2019 ident: 4156_CR46 publication-title: BioData Mining doi: 10.1186/s13040-019-0196-x – volume: 118 start-page: 24a year: 2020 ident: 4156_CR28 publication-title: Biophys J doi: 10.1016/j.bpj.2019.11.310 – volume: 4 start-page: 1640005 year: 2016 ident: 4156_CR23 publication-title: J Mol Eng Mater doi: 10.1142/S2251237316400050 – ident: 4156_CR36 – volume: 267 start-page: 727 year: 1997 ident: 4156_CR56 publication-title: J Mol Biol doi: 10.1006/jmbi.1996.0897 – volume: 14 start-page: 300 year: 2017 ident: 4156_CR38 publication-title: IEEE/ACM Trans Comput Biol Bioinform doi: 10.1109/TCBB.2015.2462364 – volume: 574 start-page: 163 year: 2019 ident: 4156_CR3 publication-title: Nature doi: 10.1038/d41586-019-03013-5 – volume: 4 start-page: 10144 year: 2021 ident: 4156_CR20 publication-title: Med Dev Sens. doi: 10.1002/mds3.10144 – volume: 49 start-page: 16 year: 2017 ident: 4156_CR31 publication-title: Acta Biomater doi: 10.1016/j.actbio.2016.11.026 – volume: 11 start-page: 3919 year: 2019 ident: 4156_CR27 publication-title: Am J Transl Res – volume: 4 start-page: 65 year: 2009 ident: 4156_CR39 publication-title: ACS Chem Biol doi: 10.1021/cb800240j – volume: 1862 start-page: 2043 year: 2018 ident: 4156_CR35 publication-title: Biochim Biophys Acta Gen Subj doi: 10.1016/j.bbagen.2018.06.011 |
| SSID | ssj0017805 |
| Score | 2.5702052 |
| Snippet | Background
Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related... Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related neural... Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning and related... Abstract Background Current methods in machine learning provide approaches for solving challenging, multiple constraint design problems. While deep learning... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 239 |
| SubjectTerms | Algorithms Amino Acid Sequence Antibacterial Antibacterial agents Antibiotic resistance Antibiotics Antiinfectives and antibacterials Antimicrobial activity Antimicrobial agents Antimicrobial Cationic Peptides Antimicrobial peptide Antimicrobial peptides Bacteria Bioinformatics Biomedical and Life Sciences Biomimetics Chemical compounds Codon Combinatorial analysis Computational Biology/Bioinformatics Computer Appl. in Life Sciences Computer applications Customization Decision making Deep learning Deoxyribonucleic acid Design DNA Drug development Drug resistance Drug Resistance, Microbial Genetic algorithm Genetic algorithms Identification and classification Immune system Learning algorithms Life Sciences Machine Learning Machine Learning and Artificial Intelligence in Bioinformatics Microarrays Microbiological research Microorganisms Neural networks Nucleotide sequence Peptides Pharmacology Pore Forming Cytotoxic Proteins Research Article Rough set theory Set theory |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggMSF9yNQkEFIHMBqHo7jnFBBVHCpKh5Sb5Zf2V2pmyybFJV_z4zX2ZIieuGYeJzEnhl7Yn_-hpBXUvPGGueZ0Kln3DeSmUKXrPaC28borLIyJJuoDg_l8XF9FBfc-girHMfEMFC7zuIa-V5e4pZYUfD83eoHw6xRuLsaU2hcJdeQJSEP0L2j7S4C8vWPB2Wk2OszZGtjCErAg-mCnU0mo8DZ__fI_MfUdBE2eWHvNExJB7f_tzF3yK0YjNL9jfXcJVd8e4_c2KSn_HWfzGGwMCGBBAUzw9OOVJ_M4DnDfElxAZcuAxTT05h7Ykb7YaSeoBANUxfwIViw6iA4HyjocbFcBPInePEKITUg84B8P_j47cMnFjMzMCt4NjDhpbRZbuCC5yZDCCtvjK21rJ3lZepS0The1drZEqxEgoR1Wpe-EUZmTV08JDtt1_rHhIoSaspCptIabi1IF4X2pS9F7RqIzhKSjSpSNtKWY_aMExV-X6RQG7UqUKsKalVnCXmzrbPakHZcKv0eNb-VRMLtcKNbz1T0X2WMzTVEx57XKeemMlVliqqwNXyjc9wl5CXajUJKjRYxOzN92vfq89cvah8TPMOfWc4T8joKNR20wep4BAJ6Alm4JpK7E0nweTstHu1KxTGnV-dGlZAX22KsiTi61nenQQZD2DyFRzzaWPO23QWEphBcVgmpJnY-6ZhpSbuYB0ZyUDCSFiXk7egR55_1745_cnkrnpKbefDVkmXZLtkZ1qf-Gblufw6Lfv08ePpvRQpeEA priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZQAYkL70egIIOQOEDUJHYc51gQFVwq1ALqzfIruyt1k9Umi-DfM-M8IOUhwXHjz9l4PGNP4plvCHkuNa-scT4WOvEx95WMDdN5XHrBbWV0WlgZik0Ux8fy7Kz8MCSFtWO0-3gkGVbqYNZSHLQpcq3FGFKAaeUiBs_xMmx3Egs2nJx-ns4OkKV_TI_5bb_ZFhSY-n9dj3_akC4GS144MQ0b0dGN_xvCTXJ9cDzpYa8pt8glX98mV_tSlN_ukCUsDCYUi6CgUpjZSPX5otmuuuWa4sdaug5hl54OdSYWtO1GmgkKni91IRYEGzYNOOIdhTlbrVeB6An-eIPhM4C5Sz4dvf345l08VGGIreBpFwsvpU0zAz94ZlIMV-WVsaWWpbM8T1wiKseLUjubg0ZIQFinde4rYWRalewe2aub2j8gVOTQUzKZSGu4tYBmTPvc56J0FXhiEUnHiVF2oCjHShnnKryqSKF6CSqQoAoSVF8j8nLqs-kJOv6Kfo3zPSGRXDtcaLYLNdiqMsZmGjxhz8uEc1OYojCsYLaEZ3SOu4g8Q21RSJ9RY3zOQu_aVr0_PVGHWMwZ3sIyHpEXA6hqYAxWD-kOIAlk3Joh92dIsG87bx6VUg3rS6uyHA-IGeNZRJ5OzdgTY-Zq3-wCBt3VLIFb3O91eBo3AzcUHMkiIsVMu2eCmbfUq2VgH4cJRoKiiLwadfzHY_1Z8A__Df6IXMuCmeRxmu6TvW6784_JFfulW7XbJ8HevwPRSFUH priority: 102 providerName: Springer Nature |
| Title | Combining genetic algorithm with machine learning strategies for designing potent antimicrobial peptides |
| URI | https://link.springer.com/article/10.1186/s12859-021-04156-x https://www.ncbi.nlm.nih.gov/pubmed/33975547 https://www.proquest.com/docview/2528903342 https://www.proquest.com/docview/2526151204 https://pubmed.ncbi.nlm.nih.gov/PMC8111958 https://doaj.org/article/bbc2a161e49044b7b77b373c9f05dd4d |
| Volume | 22 |
| WOSCitedRecordID | wos000655599300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: RBZ dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: M~E dateStart: 20000101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: P5Z dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Computer Science Database customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: K7- dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/compscijour providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-2105 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017805 issn: 1471-2105 databaseCode: RSV dateStart: 20001201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdggMQL4pvAqAJC4gGi5cOxnccNbWJCVFEHqPBi2Y7TVlrTqknR-O-5c5KyDAEvvFhKfW6Su7N9jn_-HSGvhKKl0YUNmAptQG0pAp2oNMgso6bUKuJGuGQTfDwW02mWX0r1hZiwlh64VdyB1iZWEJZYmoWUaq451wlPTFaGaVHQAkffkGf9YqrbP0Cm_v6IjGAHdYQ8bQHCEfBIOgsuBtOQY-v_fUy-NCldBUxe2TV1k9HJXXKniyL9w_bp75FrtrpPbrV5JX88IHPo5dplfvDBP_CYoq_OZ6vNopkvffzy6i8dhtL6XdKImV83PWeED2GsXzhgB1asVxBVNz4YYLFcONYmuPEasTAg85B8Pjn-9O590KVUCAyjURMwK4SJYg0XNNYRYk9pqU2mRFYYmoZFyMqC8kwVJgXzCpAwhVKpLZkWUZklj8hetarsE-KzFFqKRITCaGoMSCeJsqlNWVaAbZhHol7D0nR845j24ly6dYdgsrWKBKtIZxV54ZE3uzbrlm3jr9JHaLidJDJlux_Af2TnP_Jf_uORl2h2iVwYFYJtZmpb1_L0bCIPMTMzLKli6pHXnVC5gncwqju7AJpA-qyB5P5AEjqrGVb33iW7waKWcYq7vUlCY4-82FVjSwTAVXa1dTIYe8Yh_MXj1hl3751ATAlRIfcIH7jpQDHDmmoxd1TiYGBkG_LI296hfz3WnxX_9H8o_hm5HbsOmQZRtE_2ms3WPic3zfdmUW9G5DqfcleKEblxdDzOJyPXxaH8wIMRYnRzKPP0G9Tnpx_zr3A1OfvyE5X_WXI |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqAoIL70eggEEgDhA1DydxDgiVR9XVlgpBkXozfmV3pW522WSh_VP8RmacZEuK6K0Hjrse79rOzHgcz3wfIc-4ZIVWxvqpDKzPbMF9FcvEz23KdKFkmGnuyCayvT1-cJB_WiO_uloYTKvsfKJz1Gam8R35ZpTglVgcs-jN_LuPrFF4u9pRaDRqMbTHP-HIVr0evIfn-zyKtj_sv9vxW1YBX6csrP3Ucq7DSMEHFqkQ0y9ZoXQueW40SwITpIVhWS6NTmCGHCS0kTKxRap4WCD4Erj8CyzmGdrVMPNXtxbID9AV5vB0swoRHc7HJAgshE_9o97m5zgC_t4J_tgKT6dpnrqrdVvg9rX_bfGuk6ttsE23Guu4QdZseZNcaug3j2-RMThD5QgyKJgRVnNSeTiCcdfjKcUX1HTqUk0tbbk1RrSqO2gNCtE-NS7_BRvmMzh81BT0dDKdOHAr-OM5pgyBzG3y9VymeYesl7PS3iM0TaAnj3nAtWJag3QcS5vYJM1NAdGnR8JOJYRuYdmRHeRQuOMZT0WjRgLUSDg1EkceebnqM29ASc6UfouatpJEQHH3xWwxEq1_EkrpSEL0b1keMKYylWUqzmKdwxiNYcYjT1FPBUKGlJiTNJLLqhKDL5_FFhJYw8kzYh550QoVM5iDlm2JB6wEooz1JDd6kuDTdL-502PR-tRKnCixR56smrEn5gmWdrZ0MhiiRwH8xN3GelbzjiH0huA580jWs6vewvRbysnYIa7DA0ZQJo-86izwZFj_Xvj7Z8_iMbm8s_9xV-wO9oYPyJXI-YnED8MNsl4vlvYhuah_1JNq8ch5GUq-nbdl_ga7B7xE |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zj9MwELbQcogX7iOwgEFIPLDR5nAc53E5KlagasUC2jfLV9pK26RqUgT_nhknKZvlkBCPjT-n9nhsj-OZbwh5LhQrjbYu5CpyIXOlCHWqsrBwnJlSqzg3wiebyKdTcXJSHJ2J4vfe7sOVZBfTgCxNVbu_smU3xQXfb2LkXQvRvQBDzHkIVuRFho70eF4__rK9R0DG_iFU5rf1RtuRZ-3_dW0-szmdd5w8d3vqN6XJ9f_vzg1yrTdI6UGnQTfJBVfdIpe7FJXfb5M5LBjaJ5GgoGoY8UjV6axeL9r5kuJHXLr07piO9vknZrRpB_oJChYxtd5HBAtWNbaJwlgulgtPAAV_vEK3GsDcIZ8nbz-9fhf22RlCw1nchtwJYeJEww-W6BjdWFmpTaFEYQ3LIhvx0rK8UNZkoCkCEMYqlbmSaxGXRXqX7FR15e4TyjOoKVIRCaOZMYBOU-Uyl_HClmChBSQeBkmanrocM2icSn-EEVx2EpQgQeklKL8F5OW2zqoj7vgr-hWO_RaJpNv-Qb2eyX4OS61NosBCdqyIGNO5znOd5qkpoI3WMhuQZ6g5Emk1KvTbmalN08jD44_yAJM8w-ksYQF50YPKGvpgVB8GAZJAJq4RcneEhHlvxsWDgsp-3WlkkuHFcZqyJCBPt8VYE33pKldvPAbN2CSCV9zr9Hnb7xTMUzAw84DkI00fCWZcUi3mnpUcBhiJiwKyN-j7z2b9WfAP_g3-hFw5ejORHw6n7x-Sq4mfMVkYx7tkp11v3CNyyXxtF836sV8GfgAr9mDP |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combining+genetic+algorithm+with+machine+learning+strategies+for+designing+potent+antimicrobial+peptides&rft.jtitle=BMC+bioinformatics&rft.au=Kyle+Boone&rft.au=Cate+Wisdom&rft.au=Kyle+Camarda&rft.au=Paulette+Spencer&rft.date=2021-05-11&rft.pub=BMC&rft.eissn=1471-2105&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=17&rft_id=info:doi/10.1186%2Fs12859-021-04156-x&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_bbc2a161e49044b7b77b373c9f05dd4d |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2105&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2105&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2105&client=summon |